Alja Zottel

10PUBLICATIONS

22CO-AUTHORS

Neurology and neuromuscular diseasesPredictive and prognostic markersApplications in life sciencesGene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jun 26, 2026

Optimizing In Vitro Efficacy Assessment of the Antisense Oligonucleotide Nusinersen in Human Cellular Models.

|Feb 21, 2025

In Vitro Functional Validation of an Anti-FREM2 Nanobody for Glioblastoma Cell Targeting.

Gloria Krapež, Neja Šamec, Alja Zottel

|Feb 11, 2023

Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo.

Alja Zottel, Metka Novak, Neja Šamec

|Oct 23, 2021

Current Technologies for RNA-Directed Liquid Diagnostics.

Maria Victoria Martinez-Dominguez, Alja Zottel, Neja Šamec

|Sep 10, 2021

TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion.

Andrej Porčnik, Metka Novak, Barbara Breznik

|Aug 27, 2021

Algorithmically Deduced <i>FREM2</i> Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas.

Marianna Zolotovskaia, Victor Tkachev, Maxim Sorokin

Pageof 2

Frequent Collaborators

Ivana Jovčevska

Neja Šamec

Rok Romih

Barbara Breznik

Ana Rotter

Alja Videtič Paska

Lucija Raspor Raspor Dall'Olio

1 joint publications

Mikhail Raevskiy

1 joint publications

Andrej Zupan

1 joint publications

Marianna Zolotovskaia

Frequent Collaborators

Ivana Jovčevska

Neja Šamec

Rok Romih

Barbara Breznik